Joost van Bree

Joost van Bree (CEO) obtained an MSc and PharmD from Leiden University, after which he specialized and did his PhD in Clinical Pharmacology, also at Leiden University. From 1995 onwards, he has worked in senior management positions and C-suite positions with responsibility for drug development, strategic development, regulatory affairs, business development, and private as well as public financing (IPO and Secondary Listing). He has gained extensive experience in strategic and operational hands-on management and leadership positions. He served in executive as well as non-executive director board positions with several public and private Life Science companies, amongst which were Sandoz/Novartis, Teva, Pharming, Noviogendix, Pepscan, HealthWise Investment Group and Immunovo.